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ABSTRACT
Herpessimplexvirus-1US11isaRNA-bindingprotein
with a novel RNA-binding domain. US11 has been
reported to exhibit sequence- and conformation-
specific RNA-binding, but the sequences and con-
formations important for binding are not known.
US11 has also been described as a double-stranded
RNA (dsRNA)-binding protein. To investigate the
US11–RNA interaction, we performed in vitro selec-
tion of RNA aptamers that bind US11 from a RNA lib-
rary consisting of .10
14 80 base sequences which
differ in a 30 base randomized region. US11 bound
specifically to selected aptamers with an affinity of
70 nM. Analysis of 23 selected sequences revealed
a strong consensus sequence. The US11 RNA-
binding domain and <46 bases of selected RNA con-
taining the consensus sequence were each sufficient
for binding. US11 binding protected the consensus
motif from hydroxyl radical cleavage. RNase diges-
tions of a selected aptamer revealed regions of both
single-stranded RNA and dsRNA. We observed that
US11boundtwodifferentdsRNAsinasequencenon-
specific manner, but with lower affinity than it bound
selected aptamers. The results define a relatively
short specific sequence that binds US11 with high
affinityandindicatethatdsRNAalonedoesnotconfer
high-affinity binding.
INTRODUCTION
RNA-binding proteins play a role in many aspects of cellular
biology, especially in the regulation of gene expression, where
they are involved in virtually every stage (1). Because
RNA-binding proteins play such an important role in regulat-
ing gene expression, and viruses often need to alter the gene
expression proﬁle of the host cell to produce an environment
that is conducive to efﬁcient viral replication, it is not surpris-
ing that many viruses encode RNA-binding proteins that may
function to alter the expression patterns of viral and/or cellular
genes.
One such RNA-binding protein, herpes simplex virus-1
(HSV-1) US11, is a relatively small ( 23 kDa), highly
basic phosphoprotein (2) that is expressed late in infection
but is present at early times post-infection as it enters the
cell as a component of the virion (3). US11 is not necessary
for viral replication in cell culture or in a mouse model (4) and
its function in the HSV-1 lifecycle remains unclear. There
have, however, been some reports regarding potential func-
tions of the protein such as a role in axonal transport of the
virion (5) and the regulation of gene expression (6–10).
The domain of US11 that is sufﬁcient to bind RNA is loc-
ated within the C-terminal half of the protein, and contains an
amino acid sequence that consists almost entirely of a variable
number (20–24, depending on strain) of R-X-P tripeptide
repeats, where X is most commonly an acidic or uncharged
polar amino acid (11). This RNA-binding domain (RBD)
shows some homology to the Epstein–Barr virus SM protein
(12), but it is not homologous to any other known proteins and
thus the mechanism by which it recognizes and binds RNA
may be novel.
US11 has been reported to bind a limited number of cellular
and viral RNAs (2,3,10,13–16), but the functional relevance
of these interactions has not yet been determined. In addition,
although US11 has been reported to be a sequence- and
conformation-speciﬁc RNA-binding protein (14,17), the
sequences and/or conformations that confer binding of a
RNA molecule to US11 have not been clearly elucidated.
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doi:10.1093/nar/gki919The smallest natural RNA reported to be sufﬁcient for US11
binding is a rather long sequence, 319 bases derived from the
50 end of the UL34 transcript (15). The dissociation constant
(Kd) of the interaction between US11 and a RNA containing
319 bases of UL34 sequence along with  50 bases of vector
sequence is 100–130 nM in vitro (16), which is the highest
afﬁnity binding reported for a speciﬁc RNA–US11 interaction.
More recently, Khoo et al. (17) selected short RNA
molecules (aptamers) that bound US11-RBD in vitro but
these contained no consensus sequence (17). They also repor-
ted that the US11-RBD was able to bind double-stranded RNA
(dsRNA) in vitro containing sequences distinct from their
selected aptamers. From these and other data they concluded
that US11 is a dsRNA-binding protein.
To gain more insight into how US11 binds RNA ligands, we
used anautomated procedure to select RNA aptamersthat bind
US11. We characterized the binding reaction, including quan-
tiﬁcation of the afﬁnity of the US11–aptamer interaction. In
addition, we have investigated the secondary structure of one
of the selected aptamers and identiﬁed a shorter sequence
within this aptamer that is sufﬁcient to bind US11. We also
compared the interaction of US11-RBD with the selected apta-
mers to its interaction with double-stranded aptamer RNA.
MATERIALS AND METHODS
Expression and purification of recombinant proteins
US11 sequences, encoding both full-length protein and the
reported RBD, from HSV-1 strain KOS (GenBank accession
no. AY832929) were PCR ampliﬁed (full-length US11 pri-
mers: US11N001 and US11C162; RBD primers: US11-
RBD-R and US11-RBD-L; all primer sequences can be
accessed as Supplementary Data, Table S1) and the resulting
product contained engineered EcoRI and HindIII restriction
sites at the 50 and 30 ends, respectively. The EcoRI/HindIII
digested PCR product was cloned into EcoRI/HindIII digested
pMAL-pp, which is a plasmid derived by A. Pearson from
pMAL-c2X [New England Biolabs (NEB)] to contain a
PreScission Protease site inserted into the XmnI restriction
site, between sequences encoding maltose-binding protein
(MBP) and its fusion partner (in this case, US11) (18). The
resulting plasmids were named pMAL-pp-US11 and pMAL-
pp-US11RBD. US11 sequences in these plasmids matched
KOS genomic sequences. Expression of recombinant proteins
from E.coli strain BL21(DE3)pLysS (Novagen) was induced
with 0.3 mM isopropyl-b-D-thiogalactopyranoside (Fisher
Biotech) and the cells were grown at 37 C for 4 h after induc-
tion. Cells were then pelleted and resuspended in buffer A
(30 mM Tris–HCl, pH7.5, 2mM DTT, 0.5 mM EDTA and 5%
glycerol) in addition to 1· Complete protease inhibitor cock-
tail (Roche) and 1 M NaCl. The resuspended pellet was frozen
at  80 C. The cells were thawed slowly at 4 C and the cells
were disrupted by sonication. Cellular debris was pelleted by
centrifugation for 20 min at 30000 g and the supernatant was
applied to a column of amylose resin (NEB), equilibrated with
the buffer A and 1 M NaCl. The amylose column was washed
with three column bed volumes buffer A and 10 mM NaCl.
Bound protein was eluted with this buffer containing 10 mM
maltose. The eluate from the amylose column was applied to a
1 ml HiTrap Heparin HP column (Amersham Biosciences)
equilibrated with 20 ml buffer A and 10 mM NaCl. Bound
protein was washed with 20 ml of this buffer and was then
eluted in buffer A with a 10 mM–2 M gradient of NaCl.
Fractions were monitored by SDS–PAGE and fractions con-
taining US11 were pooled. Additional glycerol (to 25%) was
added to the fractions containing puriﬁed MBP-US11 or
MBP-US11-RBD and the protein samples were stored at
 20 C. The concentration of the puriﬁed recombinant pro-
teins was determined by amino acid analysis performed by the
Molecular Biology Core Facility at the Dana Farber Cancer
Institute. The puriﬁed protein was determined to be >90%
active as assayed by the amount of RNA that a ﬁxed amount
of US11 bound when titrated to saturation with increasing
concentrations of RNA. Puriﬁed recombinant MBP-UL42
was provided by John Randell.
In vitro selection of anti-US11 RNA aptamers
Automated selection experiments were carried out on a robotic
workstation speciﬁcally adapted for the task as described pre-
viously (19,20). Brieﬂy, the selection target, MBP-US11, was
chemically conjugated to biotin (19) and was then immobil-
ized on streptavidin-coated magnetic beads (Dynal, Lake
Success, NY). A nucleic acid pool that contained a random
sequence region that spanned 30 residues [N30; (21)] and that
had a diversity of roughly 1.1 · 10
14 unique sequences was
incubated with the target-coated beads in the presence of
selection binding buffer (50 mM Tris, pH 7.5, 200 mM
NaCl, 5 mM MgCl2 and 1 mM DTT). Nucleic acid binding
species were partitioned from the randomized pool by vacuum
ﬁltration of the target-beads followed by four washes of 250 ml
of the selection binding buffer (20). Bound species were eluted
from the MBP–US11 complex and ampliﬁed by performing
reverse transcription using AMV reverse transcriptase (AP
Biotech), PCR using Display Taq (Promega) and in vitro tran-
scribed using T7 RNA polymerase (Stratagene) into a new
RNA pool for further rounds of selection and ampliﬁcation
as described previously (19,20). Overall, 12 rounds of auto-
mated selection were performed against this target under
identical wash conditions for each round of selection. This
procedure is shown using a schematic diagram in Figure 1.
Upon completion of the 12th round of selection, reverse tran-
scription and PCR, DNA products were cloned into pCR2.1
with Invitrogen’s TA cloning kit according to the manufac-
turer’s instructions. Selected clones were sequenced using a
Dye Terminator Cycle Sequencing Kit (Beckman Coulter) on
a CEQ 200XL capillary DNA sequencer (Beckman Coulter).
Synthesis of aptamer RNA
Full-length, 80 base, aptamer RNAs were in vitro transcribed
from a PCR product containing a T7 promoter using the T7
MEGAshortscript kit (Ambion) according to the manufac-
turer’s instructions. The primers (41.30 and 24.30) used to
generate this PCR product were annealed to the constant
sequences ﬂanking the 30 bases of randomized sequence,
and thus were the same for each aptamer clone. ‘Cut’ aptamer
RNA was generated essentially in the same manner, with the
exception that the PCR product used as a template in
the in vitro transcription reaction was digested with SfcI.
The SfcI digested in vitro transcription template was gel puri-
ﬁed to ensure that undigested templates were not present in the
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the 30 end of the PCR product and the resulting transcribed
RNA is 65 bases in length. The template for the ‘short’ apta-
mer RNA was generated by amplifying a PCR product with an
upstream primerthat annealed tothe sequencejustupstreamof
the 30 base randomized sequence (C17 short). This PCR prod-
uct is missing 19 bases from the 50 end compared with the full-
length template and the transcribed RNA is 61 bases long. To
generate the template for the ‘short cut’ aptamer RNA, we
digested the ‘short’ template with SfcI and gel puriﬁed the
digested product. In vitro transcribed RNA was labeled intern-
ally by including [a-
32P]UTP [1.6 mM ﬁnal concentration and
800 Ci/mmol (NEN)] in the in vitro transcription reaction, in
addition to the unlabeled nucleotides (ATP, CTP and GTP are
7.5 mM ﬁnal concentration, UTP is 5.6 mM). In vitro tran-
scribed RNA was puriﬁed by phenol/chloroform extraction
followed by ethanol precipitation in the presence of either
0.3 M sodium acetate or 0.75 M ammonium acetate after
stopping the reaction by digesting the DNA template with
DNaseI. The pellet was washed twice with 70% ethanol
and resuspended in water. The RNA concentration was
determined by analyzing the amount of trichloroacetic acid
insoluble counts present as described previously (22).
Electrophoretic mobility shift assays (EMSAs)
All EMSAs were performed essentially as described previ-
ously (23). Brieﬂy, 5 nM internally labeled aptamer RNA
was incubated with various concentrations of protein in the
presence of 1· binding buffer (50 mM Tris, pH 8, 100 mM
NaCl and 14.4 mM 2-mercaptoethanol), 30 mg yeast tRNA
(Ambion), MTPBS and 20 U SUPERase In (Ambion). Bind-
ing was allowed to reach equilibrium by incubating samples
for 30 min at room temperature unless otherwise noted. An
aliquot of 1 ml loading buffer (0.025% bromophenol blue, 0.5·
TBE and 10% glycerol) was added to each reaction and the
entire reaction was resolved on a 5% non-denaturing polyac-
rylamide gel. RNA was visualized using dried gels to expose a
phosphor storage screen and the data were analyzed using the
Quantity One program (Bio-Rad).
Fe-EDTA hydroxyl radical footprinting
Aptamer RNA was in vitro transcribed as described above
with the exception that [a-
32P]ATP was not included and
7.5 mM of all NTPs were used. This RNA was puriﬁed by
phenol/chloroform extraction followed by ethanol precipita-
tion in the presence of 0.75 M ammonium acetate. The RNA
pellet was washed with 70% ethanol and resuspended in water.
This RNA was dephosphorylated by calf intestinal alkaline
phosphatase and phosphorylated with polynucleotide kinase
using [g-
32P]ATP [167 mCi/ml, >7000 Ci/mmol (ICN)] using
the KinaseMax kit (Ambion). Labeled RNA was resolved on a
12% denaturing polyacrylamide gel and the full-length prod-
uct was visualized by autoradiography, and the corresponding
gel slice was excised and crushed with a pipette tip. RNA was
eluted from the crushed gel overnight in 300 ml in crush and
soak buffer (500 nM NH4OAc, 10 mM Mg(OAc)2,1m M
EDTA and 0.1% SDS) at 4 C, followed by a second elution
step with 100 ml crush and soak buffer for 1 h at 37 C. Eluted
RNA was phenol/chloroform extracted, ethanol precipitated
and washed with 70% ethanol and the pellet was resuspended
in RNA renaturation buffer (10 mM NaH2PO4, 50 mM NaCl,
3 mM MgCl2 and 0.1 mM EDTA). RNA was denatured by
heating to 80 C for 5 min and renatured by slowly cooling the
sample to 25 C at a rate of 0.033 C/s. Binding reactions with
MBP-US11-RBD were performed as described above with
the exception that 1.5 mg yeast tRNA was added, rather
than 30 mg. After the binding reaction was allowed to reach
equilibrium, 1 ml each of 25 mM ammonium iron (II) sulfate
hexahydrate, 50 mM EDTA, 100 mM ascorbic acid and 3%
hydrogen peroxide were added to the reaction. Samples were
incubated for 1 min at room temperature, vortexed and incub-
ated for an additional minute at room temperature. The reac-
tion was stopped by the addition of 100 mM thiourea.
Following the hydroxyl radical cleavage reaction, the samples
were phenol/chloroform extracted and ethanol precipitated in
the presence of GlycoBlue (Ambion). Precipitated RNA was
washed with 70% ethanol and resuspended in loading buffer II
(Ambion). RNase T1 digestions and alkaline hydrolysis
reactions were performed as directed by the manufacturer.
Samples were resolved on a 12% sequencing gel (SequaGel;
National Diagnostics) at a constant power of 40 W. The gel
was dried and used to expose a Bio-Rad phosphor storage
screen.
RNase digestion
Aptamer RNA was in vitro transcribed, end-labeled, puriﬁed,
denatured and renatured in the same manner as the
RNA prepared for Fe-EDTA footprinting. RNase digestions,
as well as alkaline hydrolysis of the RNA were carried out
Figure 1. Simplified scheme for in vitro RNA selection. A random RNA pool
(RNA shown as blue squiggles) is incubated with the selection target, MBP-
US11 (shown as green crescents), immobilized on magnetic beads (shown as
purple circles). The bead-bound complexes are washed to remove low-affinity
nucleic acid binding species (thin blue squiggles). Next, tightly bound RNA
molecules (thick blue squiggles) are eluted from the target and reversed
transcribed, PCR amplified, and in vitro transcribed in order to regenerate
the RNA pool. The delimited pool is then incubated with a new aliquot of
the immobilized target, and the selection cycle begins again.
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grade RNase A, T1 and V1; Ambion). We used 10 and 1 ng
RNase A, 0.1 and 0.01 U RNase T1 and 0.001 and 0.0001
U RNase V1 per reaction, each in a separate reaction. For
alkaline hydrolysis, samples were incubated at 100 C for 2
and 5 min in alkaline hydrolysis buffer (Ambion). Following
RNase digestion, reactions were stopped by ethanol precipita-
tion of the RNA. The precipitated RNA was washed with 70%
ethanol and was resuspended in loading buffer II (Ambion).
Samples were resolved on a 12% sequencing gel (SequaGel;
National Diagnostics) at a constant power of 40 W. The gel
was dried and used to expose a Bio-Rad phosphor storage
screen.
Generation of antisense and double-stranded
aptamer RNA
The template used to in vitro transcribe RNA antisense to
the selected aptamers was created by PCR using a set of
primers that contain the T7 promoter on the opposite primer
than that used to generate the templates for the sense strand
aptamer RNA [41.30 ( T7) and 24.30 (+T7)]. Antisense
RNA was in vitro transcribed, puriﬁed and quantiﬁed in the
same manner as the sense strand aptamer RNA. dsRNA was
generated by annealing sense and antisense strands as
described previously (17). Unhybridized RNA was digested
with 1000 U RNase T1 (cloned grade; Ambion) and 2 ng
RNase A (biochemistry grade; Ambion) at room temper-
ature. Following digestion, samples were resolved on a 5%
non-denaturing polyacrylamide gel. The portion of the gel
containing dsRNA was visualized by autoradiography,
excised, eluted and puriﬁed as described above, with the
exception that the RNA was resuspended in water. The
double-stranded nature of the RNA was conﬁrmed by its res-
istance to the single-strand-speciﬁc RNases A and T1 and
sensitivity to the double-strand-speciﬁc RNase V1 (data not
shown).
Determination of Kd values
The equationused todetermine the Kdvaluesin this report was
derived from the following two equations: r ¼ð C CS  CSÞ= C CA
and r ¼ pCS/(Kd + CS) where r is a binding function deﬁned
as the molar ratio of the amount of bound ligand to the total
amount of acceptor, p is the number of independent and
equivalent binding sites on the acceptor (which we observed
to be 1 for the selected aptamer acceptor and to be 3 for the
double-stranded aptamer RNA acceptor),  C CS is the total ligand
concentration (which in this case is total protein concentra-
tion), CS is the free ligand concentration (which in this case is
unbound protein concentration),  C CA is the total acceptor con-
centration (which in this case is total RNA concentration) (24).
The two equations were set equal to each other to give
the following equation: ð C CS  CSÞ= C CA ¼ pCS=ðKd þ CSÞ.
Rearranging the terms in this equation to solve for Kd gives
Kd ¼ pCS C CA=ð C CS  CSÞ  C CS, which is the equation we used
to calculate the Kd values in this report. Kds were calculated
using CS ¼ total protein since unbound protein was in
great excess over bound protein. For the ð C CS  CSÞ term,
which is the concentration of the bound protein–RNA
complex, we used the concentration of bound RNA since
this value could be directly measured. The Kds were determ-
ined using a RNA concentration of 5nM and a range of protein
concentrations. Kds are presented as an average of the
values, measured in triplicate and obtained at each protein
concentration.
RESULTS
In vitro selection of RNA aptamers that bind US11
We performed 12 rounds of automated selection for aptamers
that bound MBP-US11. A total of 23 selected aptamers were
cloned and sequenced, and from this pool there emerged
a consensus (UUCGCAAUYCUGCAYUG, where Y is a pyr-
imidine base) within the selected sequences (Figure 2).
Figure 2. Selected anti-US11 aptamers. Sequences cloned from the random sequence pool after 12 rounds of selection and amplification are shown. The constant
priming region is shaded in light gray; the random region is in black text and sequences with high similarity in the random region are highlighted in red text. The
consensus sequence is shown at the bottom of the figure (Y ¼ pyrimidine, C or U).
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with the selected aptamer RNA species, we performed
EMSAs with puriﬁed recombinant MBP-US11 and in vitro
transcribed aptamer RNA. This permitted us to assess whether
the aptamers exist as one or more stable conformers and
whether they contain one or more US11-binding sites. We
analyzed four of the selected aptamers, clone 13 (C13),
C16, C17 and C22, that differed from one another both
inside and outside of the 17 nt consensus region (Figure 2).
Figure 3A shows that aptamer C17 migrated as a single band
on a native polyacrylamide gel in the absence of US11,
suggesting that it exists as a single major conformer. With
increasing concentrations of US11, a single band of lower
mobility appeared, indicating that there is one speciﬁc
US11-binding site present in this selected aptamer
(Figure 3A). Similar data were obtained for each of the
three other aptamers tested (data not shown).
To determine whether the RBD of US11 was sufﬁcient for
the observed binding,weexpressedandpuriﬁedthisdomainof
US11 fused to MBP. This recombinant protein bound to the
selected aptamer C17 (Figure 3B).
The aptamers were selected to bind US11 that was
expressed and puriﬁed as an MBP fusion protein. To show
that the binding was speciﬁc to the US11 moiety of the fusion
protein, we performed EMSAs with MBP fused to another
nucleic acid binding protein, UL42, which is the processivity
factor forthe HSV-1 DNA polymerase andcanbindDNA with
nanomolar afﬁnity (25). MBP-UL42 did not bind the selected
aptamer RNA detectably (Figure 3C), indicating that the inter-
action is speciﬁc to the US11 moiety.
To assess whether the US11–aptamer interactions were
speciﬁc for the selected aptamers, we performed EMSAs
with an aptamer that was not selected to bind US11. US11
did not detectably bind an aptamer that was selected to bind
heneggwhitelysozyme(lyso,sequenceinFigure4)(19),even
at the highest concentrations of protein assayed (Figure 3D).
To provide further evidence for the speciﬁcity of the interac-
tion of US11 with the selected aptamers we also performed
competition experimentsinwhich unlabeledselected aptamers
competed the binding of US11 from labeled selected aptamer
RNA, but unlabeled lyso aptamer RNA did not compete
binding (data not shown).
Mapping the US11-binding site on a selected aptamer
Since the US11–RNA EMSAs indicated that there is one bind-
ing site for US11 on the selected aptamers, we attempted to
deﬁne a smaller RNA sequence that is sufﬁcient to confer
US11 binding. We made 50 and/or 30 truncations of the C17
aptamer RNA (Figure 4) and assayed the ability of these
truncated RNAs to bind US11 by performing EMSAs. Delet-
ing either the 50 (short) or the 30 (cut) end of aptamer C17 RNA
resulted in RNA species that were still sufﬁcient to bind US11
(Figure 5A and B). This indicates that although the constant
ﬂankingsequenceattheendsoftheRNA maycontributetothe
ability of RNA to bind US11, they are not necessary for US11
binding.
US11alsoboundtoaRNA species lacking boththe 50 and30
sequences (short-cut), but only  25% of this RNA was cap-
able of binding in vitro at room temperature (data not shown).
Much more RNA bound US11 when the EMSAs were
performed at 4 C (Figure 5C), most probably owing to a
greater proportion of the RNA folding into a conformation
that was competent to confer US11 binding. US11 bound full-
length aptamers under these conditions with the same afﬁnity
as the case when the assay was performed at room temperature
Figure 3. Binding of US11 to the selected aptamers is specific. (A) RNA
EMSA was performed by incubating an internally labeled representative
selected RNA aptamer, C17, either without protein (0), or with increasing
concentrations of MBP-US11 (11.5, 23, 46, 92, 122, 183, 367, 550 and
1100 nM final concentrations). Bound complexes were resolved from free
RNA by electrophoresis in 5% native polyacrylamide gels. (B) C17 RNA
incubated with either no protein (0), or increasing concentrations of the
RNA-binding domain of US11 fused to MBP (9.375, 18.75, 37.5, 76, 150,
300, 600, 1200 and 2400 nM final concentrations). (C) C17 RNA incubated
with either no protein (0), or a protein that it was not selected to bind,
MBP-UL42(87.5,185,350and700nMfinalconcentrations).(D)RNAEMSA
performed as in (A), with the exception that a RNA aptamer selected for
binding to hen egg white lysozyme (lyso) was incubated with MBP-US11.
All gels were dried and used to expose phosphor storage screens. Screens were
then scanned by a Bio-Rad phosphorimager.
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consisting of 21 bases, including the selected consensus
sequence, did not bind US11 (data not shown). We conclude
from these experiments that the binding site for US11 is con-
tained within a 46 base segment of one of the selected aptamer
RNAs, which consists mainly of the selected sequence and
contains the consensus motif.
In the cases of short and short-cut RNAs, the free probe
migrated as more than one band on a native polyacrylamide
gel (Figure 5A and C). These RNAs migrated as one band on
a denaturing gel (data not shown), which suggests that the
multiple bands were structural conformers. In the presence
of US11 there was also more than one shifted band on native
gels (Figure 5A and C), suggesting that these truncated RNAs
may fold into more than one detectable RNA conformer that
can bind US11.
Fe-EDTA hydroxyl radical footprinting of US11-RBD
In an effort to map the US11-binding site on a selected
aptamer more ﬁnely, we performed an Fe-EDTA hydroxyl
radical footprinting assay. In this assay, US11-RBD protected
a portion at the 50 end ofthe selected sequence of aptamerC17,
bases 26–43 (Figure 6). Increasing concentrations of US11-
RBD led to decreasing levels of hydroxyl radical cleavage in
this region and although the protection was not complete, it
was reproducible. The region of RNA that was protected is
present in the 46 base RNA that is sufﬁcient to bind US11.
In addition, the protected sequence corresponds almost
exactly to the selected consensus motif, which is located in
bases 24–40.
Binding of US11-RBD to aptamer C17 also resulted in sites
more frequently cleaved by hydroxyl radical cleavage outside
of the region that was protected, especially in the area 50 to the
protected segment (Figure 6). These data suggest that US11
may affect the higher order structure of RNAs that it binds, at
least at close proximity to its binding site.
RNase structure mapping of selected aptamers
It has been reported that US11 binds RNA by a mechanism
that is dependent on substrate RNA being in a speciﬁc con-
formation, possibly double-stranded in nature (14,17). In an
effort to elucidate the RNA conformation of the sequences that
bind US11, we attempted to determine the secondary structure
of one of the selected aptamers, C17. We assayed the sensit-
ivity and resistance to single-strand-speciﬁc RNases A and T1
and double-strand-speciﬁc RNase V1. The RNase digestion
pattern indicated that this aptamer contains regions of both
single-stranded and double-stranded nature throughout its
length (Figure 7). In particular, there are multiple bases that
are digested by the single-strand-speciﬁc RNases A (bases 28
and 36) and T1 (bases 27, 35 and 40) in the region of C17 that
US11 protects from hydroxyl radical cleavage. There are also
Figure 4. Sequencesoftruncatedaptamers.ThesequencesofaptamerC17,shorterversionsofC17,andtheaptamerselectedtobindheneggwhitelysozyme(lyso)
used in the assays mappingthe binding site on this aptamer are listed. Constant flanking sequences are listed in gray, the selected sequence is listed in black and the
consensus sequence is in boldface.
Figure 5. MappingofUS11-binding siteon a selected aptamer.Internallylabeled(A) shortC17 RNA,(B) cutC17 RNA,or (C) short-cutC17RNA incubatedwith
either no protein (0), or increasing concentrations of MBP-US11 as described in the legend to Figure 1. Some RNAs existed as more than one conformation when
not bound to protein [*: (A and C)], which may result in the additional shifted bands that appear at the high protein concentrations (arrows).
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speciﬁc RNase V1 (bases 25, 26, 34, 43–46, 48 and 51). These
data indicate that US11 is able to recognize and bind a RNA
that is not simply double-stranded.
US11 binds double-stranded aptamer
RNA, but non-specifically
To further investigate the ability of US11 to bind dsRNA, we
made aptamer RNA double-stranded by hybridizing it to its
complementary strand and determined how this affected US11
binding. In these experiments we examined two different
aptamers, C17, which binds US11 and its RBD and the
lyso aptamer, which did not show any detectable binding to
US11 or its RBD. We performed the dsRNA-binding assays
with the RBD of US11 since this was the domain that was used
by Khoo et al. (17) to originally characterize the dsRNA-
binding activity of US11. We ﬁrst examined whether US11-
RBD bound RNAs antisense (a) to either C17 or lyso to
determine whether these sequences could contribute to any
observed binding of US11-RBD to dsRNA. US11-RBD did
not detectably bind either of the single-stranded antisense
aptamer RNAs (Figure 8A and B). Since both the selected
C17 sense and non-selected aC17 antisense aptamer RNAs
contain the ability to form the same intramolecular double-
stranded regions, yet only the selected C17 sequence can bind
US11-RBD, the double-stranded nature of the aptamers is not
alone sufﬁcient to confer US11 binding. US11–RBD bound
bothdouble-stranded C17 and lyso aptamerspecies (Figure 8C
and D). The observed binding of US11-RBD to the dsRNA
differed qualitatively from binding to the single-stranded C17
aptamer, as indicated by the multiple shifted bands that appear
as the concentration of US11-RBD increases (Figure 8C
and D). This pattern of shifted bands is consistent with non-
speciﬁc dsRNA binding by US11. At highest concentrations
of US11-RBD, the probe primarily migrated as the band with
slowest mobility. Since there are three major bands that appear
with increasing US11-RBD concentration, these data suggest
that the dsRNA aptamers can bind three molecules of US11-
RBD, most probably without sequence speciﬁcity.
The US11-RBD binds selected aptamers with higher
affinity than it non-specifically binds dsRNA
To further characterize the RNA-binding properties of US11,
we determined the afﬁnity of the interaction of US11 with a
subset of the selected aptamers as outlined in Materials and
Methods. Aptamer C17 bound US11 with a Kd of  70 nM
(example of data in Figure 3A).
Since US11-RBD seemed to bind selected aptamers differ-
ently from dsRNA, based on the different patterns of shifted
bands, we next wanted to compare the afﬁnity of US11-RBD
for the selected aptamers to that for the dsRNA. The afﬁnity
for the interaction between US11-RBD and the selected apta-
mers was  6-fold higher than the afﬁnity of US11-RBD
Figure 6. Fe-EDTA hydroxyl radical footprinting of the MBP-US11-RBD–
C17 RNA interaction. End-labeled C17 RNA was incubated with Fe-EDTA
hydroxyl radical solution, as described in Materials and Methods, either in the
presence of US11 buffer (no prot) or in the presence of decreasing concentra-
tions of MBP-US11-RBD (19, 3.8 and 0.76 mM final concentrations). These
RNAs were also digested withRNase T1 underdenaturingconditions (T1) and
cleaved by alkaline hydrolysis (alk hyd) to help determine where in the RNA
thefootprintswerelocated.UntreatedRNAwasalsorun(0).Aschematicofthe
aptamer RNA is diagrammed to the left of the gel, along with the consensus
motif, and the regions of the RNA that are protected from or hypersensitive
to hydroxyl radical cleavage are diagrammed to the right of the gel. Bases
sensitive to digestion by RNase T1 are numbered to the right of the aptamer
schematic diagram.
6096 Nucleic Acids Research, 2005, Vol. 33, No. 19for dsRNA. The Kd for the US11-RBD–C17 interaction was
220 nM and the Kd for the interaction between US11-RBD and
either species of dsRNA was  1200–1400 nM (Table 1).
Therefore, in addition to US11-RBD binding to dsRNA in a
seemingly non-speciﬁc manner, this interaction has a
lower afﬁnity than its speciﬁc interaction with the selected
aptamers.
DISCUSSION
US11 binds tightly and specifically to the selected
aptamers
After we initiated ourstudy, Khoo etal.(17)reported selection
of aptamers that bind US11-RBD. However, their study did
not measure the afﬁnity of binding to any of the aptamers.
Additionally, the size and location of the US11-binding site
within their selected aptamers were not reported and there did
not appear to be an obvious sequence consensus motif selec-
ted. In their study, the selected aptamers seem to adopt mul-
tiple conformations that differed in their ability to bind US11
but the structures of the conformers that were competent to
confer US11 binding were not investigated. Since this previ-
ous study left some questionsregarding RNA binding by US11
unanswered, we continued our studies in an attempt to better
deﬁne the RNA-binding properties of US11.
The RNA molecules that we selected in vitro have the
ability to bind US11 with high afﬁnity; the Kd for the
US11–C17 aptamer RNA interaction is  70 nM. This is
the highest afﬁnity yet reported for a speciﬁc US11–RNA
interaction. Unlike the aptamers selected by Khoo et al.
(17), we observed one free probe band and one speciﬁc shifted
band upon US11 binding for our selected aptamers, indicative
of one major conformer in each state. We interpret these
data to mean that there is one detectable binding site for
US11 on the selected aptamers, and that the binding is speciﬁc.
This binding seems to be predominantly mediated by the RBD
of US11.
Upon analysis of the sequences of the aptamers that bind
US11, there emerged a strong consensus motif in the 50 half
of the selected sequence (Figure 2, UUCGCAAUYCUGCA-
YUG, where Y indicates a pyrimidine base). However, neither
this consensus nor any of the selected aptamer sequences
seem to be present in the HSV-1 genome. It is possible that
we did not identify sequences previously known to bind US11,
including the sequences selected in vitro by Khoo et al. (17),
because these interactions may have a lower afﬁnity, and thus
would not be selected by our protocol. Alternatively, the
sequences known to bind US11 may fold into structures
that mimic the structure of our selected aptamers and these
structures may be more important for US11 binding than the
primary sequence of the RNA.
US11 binds to a specific aptamer segment
The binding site for US11 in one of these selected aptamers,
C17, was 46 bases or less in length, mainly consisting of the
selected RNA sequence. This is the shortest sequence reported
to be sufﬁcient for binding US11. The consensus sequence lies
within the short-cut 46 base aptamer and experiments assaying
hydroxyl radical footprinting of US11-RBD binding revealed
that this region is protected. These data suggest that the con-
sensus motif is a determinant that forms at least part of the
US11-binding site.
Figure 7. RNase structure mapping of a selected aptamer. End labeled C17
RNA was digested with RNases A, T1 and V1, as described in Materials and
Methods, to determine regions of the RNA that had single-stranded or double-
stranded nature. C17 RNA was also run untreated (lane 1) and was cleaved
by alkaline hydrolysis (lanes 11–13). A schematic of the aptamer RNA is
diagrammed to the left of the gel, along with the consensus motif. Bases
sensitive to digestion by the various RNases are numbered. The region of
RNA protected from Fe-EDTA hydroxyl radical footprinting is shown on
the right of the gel. A diagonal line in lanes 9–13 is a result of a crease in
the gel created as the gel was dried.
Nucleic Acids Research, 2005, Vol. 33, No. 19 6097Data generated from RNase structure mapping indicate that
selected aptamer C17 forms a structure that contains both
single-stranded RNA and dsRNA sequences. The region of
the RNA that is protected from hydroxyl radical cleavage also
contains regions of both single-stranded RNA and dsRNA. It
has been previously reported that US11 can bind speciﬁc RNA
structures (14,17), in particular dsRNA (10). However, neither
the structures of the viral or cellular US11 ligands that have
been reported nor the aptamers selected by Khoo et al. (17)
have been investigated. Our data indicate that a RNA, which is
not completely double-stranded, is able to bind US11 with
high afﬁnity in vitro, and provide the ﬁrst experimental evid-
ence that there are structures other than simple dsRNA recog-
nized by US11.
US11 binds dsRNA differently than it
binds selected aptamers
US11 has recently been reported to bind dsRNA in vitro, and
accordingly, it has been termed a dsRNA-binding protein (17).
Although this study showed that US11 can bind dsRNA, we
examined the US11–dsRNA interaction in greater detail to
determine whether there were any discernible differences
between this mode of binding and the speciﬁc binding of
US11 to the selected aptamers. Our data indicate that although
US11 can bind dsRNA, the binding appears to be non-speciﬁc
and the interaction has a lower afﬁnity than the speciﬁc bind-
ing to selected aptamers. In the case of the lyso aptamer,
neither the sense nor the antisense RNA can bind US11-
RBD, but when these two strands are annealed, US11-RBD
can bind to the resulting dsRNA. This binding exhibits an
afﬁnity and pattern of shifted bands as the binding similar
to dsC17 RNA, which contains a sequence that US11-RBD
speciﬁcally binds. This indicates that, in this case, the double-
stranded nature of the RNA was the major determinant to
confer US11 binding, rather than the sequence. To our know-
ledge, there has never been a report where US11 did not bind
dsRNA, provided the dsRNA was of sufﬁcient length. Given
this,itisinterestingthatwe didnotselect anyaptamersthat are
Figure 8. Non-specificbindingofMBP-US11-RBDtodsRNA.(A)InternallylabeledantisenseaptamerC17wasincubatedwitheithernoprotein(0),orincreasing
concentrationsofMBP-US11-RBD (9.375,18.75,37.5,75, 150,300,600,1200or2400nM finalconcentrations).(B) Antisenselysoaptamer,(C) double-stranded
C17 RNA and (D) double-stranded lyso RNA was incubated with or without protein as in (A).
Table 1. Dissociation constants (Kds) for binding of RNAs by US11-RBD
RNA Kd (nM)
C17 220 ± 60
a
Lyso n.d.
b
dsC17 1400 ± 170
dsLyso 1200 ± 200
aValues reported ± SD.
bNo binding detected.
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due to the lower afﬁnity binding of US11 to these RNAs. It
is also possible that our selection protocol may have
preferentially reverse transcribed or PCR-ampliﬁed aptamers
without extensive double-stranded nature, which might
exclude some US11 ligands such as those that are double-
stranded.
Khoo et al. (17) reported that His-tagged full-length US11
bound an 81 bp dsRNA with an apparent Kd of 12.6 nM (17).
Our data raise the possibility that this value is an overestimate
of the afﬁnity as the ﬁlter binding assay used would not
account for the multiple binding sites for US11 on the
dsRNA. We also speculate that the positively charged His-
tag might have contributed to binding.
Possible roles for US11 RNA binding
during HSV-1 infection
US11 has been shown to bind dsRNA (17) and this binding
may alter gene expression in infected cells. US11 plays a role
in the global stimulation of translation late in infection (9),
possibly through its interaction with dsRNA and/or other pro-
teins that can bind dsRNA, such as PKR. However, if RNA
molecules exist in infected cells that have sequences and/or
structures that are similar to the selected aptamers, which
US11 binds speciﬁcally with high afﬁnity, it is possible that
US11 would preferentially bind those RNA species rather than
dsRNA, which US11 binds non-speciﬁcally with lower afﬁn-
ity. Such speciﬁc binding might also play a role in the viral
lifecycle.
Examples of speciﬁc regulation of gene expression by US11
have previously been reported for the cases of viral genes
UL13 and UL34 (10,15). In these reports, US11 has been
reported to speciﬁcally bind the transcripts encoded by
these genes, possibly by a mechanism similar to the speciﬁc
binding of US11 to our selected aptamers. Our results raise the
intriguing possibility that speciﬁc binding of RNAs by US11
could be required for the regulation of gene expression. Such
binding could recruit trans-acting factors involved in the
stimulation or inhibition of gene expression, impede the trans-
lational machinery, or alter RNA stability or the subcellular
localization of bound transcripts. Since US11, when bound to
selected aptamers, generates sites that are hypersensitive to
hydroxyl radical cleavage, in addition to sites that are protec-
ted, itispossiblethatUS11may alter the higherorder structure
of RNA that it binds during infection. This could potentially
alter the expression of bound transcripts by changing the pro-
ﬁle of RNA-binding proteins able to bind these mRNAs and in
turn also possiblychange the subcellular localization,stability,
or translational efﬁciency of these transcripts, all of which
could alter their expression.
Since US11 has both speciﬁc and non-speciﬁc RNA binding
activities in vitro, it is possible that US11 may also bind RNA
via both mechanisms in infected cells and thus have both
speciﬁc and non-speciﬁc activities in the regulation of gene
expression during HSV-1 infection.
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